gabelli healthcare & wellness tr - GRX
GRX
Close Chg Chg %
10.01 -0.02 -0.20%
Closed Market
9.99
-0.02 (0.20%)
Volume: 19.82K
Last Updated:
Oct 23, 2026, 3:46 PM EDT
Company Overview: gabelli healthcare & wellness tr - GRX
GRX Key Data
| Open $10.00 | Day Range 9.95 - 10.01 |
| 52 Week Range 8.64 - 10.20 | Market Cap $146.61M |
| Shares Outstanding 14.54M | Public Float 14.29M |
| Beta 0.82 | Rev. Per Employee N/A |
| P/E Ratio 18.34 | EPS N/A |
| Yield 678.64% | Dividend $0.17 |
| EX-DIVIDEND DATE Sep 16, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 14.23K |
GRX Performance
| 1 Week | -1.29% | ||
| 1 Month | 3.00% | ||
| 3 Months | 4.18% | ||
| 1 Year | 7.10% | ||
| 5 Years | -26.49% |
GRX Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
An error occurred while fetching the data.
SEC Filings for Gabelli Healthcare & Wellness Tr - GRX
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Gabelli Healthcare & Wellness Tr - GRX
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Oct 9, 2026 | Saba Capital Management LP | 2,171,941 | Open market or private purchase of non-derivative security Non-derivative transaction at $9.43 per share | 20,481,403.63 |
| Oct 5, 2026 | Saba Capital Management LP | 2,162,772 | Open market or private purchase of non-derivative security Non-derivative transaction at $9.35 per share | 20,221,918.20 |
| Jan 13, 2026 | Gabelli & Company Investment Advisers, Inc. Director | 8,990 | Open market or private purchase of non-derivative security Non-derivative transaction at $9.58 per share | 86,124.20 |
| Dec 5, 2025 | Mario Joseph Gabelli Director | 239,425 | Open market or private purchase of non-derivative security Non-derivative transaction at $9.69 per share | 2,320,028.25 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 9,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.12 per share | 83,767.20 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 7,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.2 per share | 66,102.00 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 6,985 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.5 per share | 66,357.50 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 6,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.5 per share | 58,757.50 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 5,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.26 per share | 48,013.10 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 4,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.27 per share | 38,794.95 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 3,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.15 per share | 29,142.75 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 2,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.12 per share | 19,927.20 |